Background. Although the capability of extracorporeal treatments after administration of contrast media to prevent radiocontrast-induced nephropathy is controversial, haemodialysis is performed in many institutions after radiographic procedures. There are con¯icting reports on the ef®cacy of different dialysers and treatment modalities to remove contrast media. Methods. We compared the contrast medium-removing ability of different extracorporeal treatments in a randomized trial. Thirty-nine patients on chronic renalreplacement therapy or with chronic renal failure were randomized to receive low-¯ux haemodialysis (Low-HD, n 10), high-¯ux haemodialysis (High-HD, n 10), online haemodia®ltration (HDF, 10 litre substitution, n 10) and online haemo®ltration (HF, 18 litre substitution, n 9) after administration of contrast medium during routine radiological procedures. Plasma concentrations of contrast medium (iopromide or iomeprol) were measured by energy-dispersive X-ray¯uorescence analysis. Results. The extraction ratio for contrast media was 0.64"0.1 for Low HD (P-0.05 vs High-HD and vs HDF), 0.74"0.1 for High-HD (P-0.05 vs HF), 0.81"0.1 for HDF (P-0.05 vs HF), and 0.62"0.1 for HF. Mean extracorporeal plasma clearances were 82"2 for Low-HD (P-0.05 vs High-HD and vs HDF), 100"2 for High-HD, 115"4 for HDF (P-0.05 vs HF), and 86"5 mlumin for HF. Conclusions. We conclude that HDF and High-HD remove contrast media more effectively than Low-HD and HF during the time of each treatment session. However, whether this is also true for the overall elimination of contrast media by these different procedures needs to be addressed in future studies, by a precise assessment of the drug time course after the session.
Introduction
Radiocontrast-induced nephropathy (RCN) is a wellrecognized complication of radiographic procedures. The incidence of RCN varies between 0 and 100%, depending on the de®nition of RCN and of the population studied. In non-diabetic patients with normal renal function, the incidence of RCN is 2% [1] . For patients with chronic renal insuf®ciency, the incidence of RCN rises to about 7%, and for patients with diabetes mellitus and chronic renal failure, it is )50% [2] . Several strategies have been proposed to prevent RCN including hydration with hypotonic saline [3] , administration of calcium-channel blockers [4] , atrial natriuretic factor [5] or theophylline [6] . Although the ability of extracorporeal treatments after administration of contrast media to prevent their nephrotoxicity is controversial, haemodialysis is performed in many institutions after radiographic procedures to remove contrast media and to prevent RCN. Lehnert et al. [7] demonstrated that haemodialysis eliminates contrast medium, but it does not in¯uence the incidence of RCN. There may be several reasons for the failure of haemodialysis to prevent RCN. Firstly, the time between administration of contrast medium and start of dialysis was too long and nephrotoxicity had occurred before start of dialysis. Secondly, contrast medium was not removed ef®ciently enough to have a favourable effect on RCN. Indeed, in the cited study using a relatively low blood¯ow of 139" 8 mlumin, only one-third of the contrast-medium dose was removed [7] .
Studies investigating whether dialysis prevents RCN should apply the treatment modality that is most ef®cient for removing contrast media. Therefore the knowledge of contrast-media clearances by different dialysis modalities is essential. There are con¯icting reports on the ability of different dialysers and treatment modalities to remove contrast media. In vitro studies demonstrated that with increasing transmembranous pressure, a high-¯ux dialyser has a higher sieving coef®cient than a low-¯ux dialyser [8] . Another in vitro study reported that HDF could remove contrast media more effectively than HF [9] . This ®nding can be anticipated considering the molecular weight of the tested substance (723 kDa). In contrast, Matzkies et al. [10] demonstrated no difference in iopromide clearance between high-¯ux and low-¯ux dialysers in vivo. There are no studies comparing different extracorporeal treatment modalities for their ability to remove contrast media in vivo. We therefore conducted a randomized study comparing low-¯ux haemodialysis (Low-HD), high-¯ux haemodialysis (High-HD), haemodia®ltration (HDF), and haemo®ltration (HF) for their ability to remove contrast media.
Subjects and methods
The study was approved by the clinic's ethic committee. The elimination of contrast media was studied in 39 patients. Twenty-six patients were on chronic dialysis treatment without residual renal function, 13 patients had chronic renal insuf®ciency (serum creatinine )4 mgudl) not yet dialysisdependent. All patients underwent a radiographic procedure (computed tomography, n 5; coronary angiography; n 20 or angiography of peripheral arteries, n 14) and gave informed consent to the study. Inclusion of patients into the study was decided by two nephrologists (RS or KL) who informed the person (CS) who randomized patients into one of four treatment groups by random procedure. Group 1 (n 10) received Low-HD (Hemophan GFS 16 plus, 1.6 m 2 ; Gambro, Hechingen, Germany), group 2 (n 10) received High-HD (PF14S, 1.3 m 2 , polyamide, Gambro). Group 3 (n 10) was treated by haemodia®ltration with online preparation of substitution¯uid (PF14S, polyamide, Gambro, 10 litre substitution¯uid), group 4 (n 9) was treated by haemo®ltration with online preparation of substitution uid (HF14, 1.3 m 2 , polyamide, 18 litre substitution¯uid). The blood¯ow was kept at 200 mlumin for all procedures, the dialysate¯ow was 500 mlumin for the ®rst three groups. Twenty-one patients had an AV-®stula, ®ve had a PTFE-graft, and 13 were dialysed using a temporary doublelumen catheter. Non-ionic monomeric iopromide (Ultravist, Schering, molecular weight 791) or iomeprol (Imeron, Byk Gulden, molecular weight 777) was used. After the radiographic procedure, patients were transferred immediately to the dialysis ward and dialysed as soon as possible. The time interval between the ®rst injection of contrast media and the start of extracorporeal treatment was recorded and averaged 1.2"0.6 h.
Blood samples were taken at 0.5, 1, 2, 4 and 24 h after start of dialysis. At 1 h, blood samples were taken before and after the dialyser for calculation of extraction rate and extracorporeal clearance. Blood was centrifuged immediately; plasma was obtained and stored at À 208C until analysis.
Creatinine clearance was estimated using the equation of Cockroft and Gault:
Cr Cl : 140 À age years 3 body weight kg= 72 3 SÀCr mg=%:
Extraction ratio and extracorporeal clearance of contrast media was calculated as follows:
Extraction ration ER C in ÀC out =C in where C in is the concentration of contrast medium entering the dialyser and C out the concentration leaving the dialyser.
Extracorporeal clearance CL extra ER Ã blood flow
The elimination half-life (t 1u2 ) of contrast medium was calculated as:
where k d is the rate constant of elimination of contrast medium, which was calculated from the semilogarithmic concentration-time curve during dialysis.
Plasma concentration of iopromide or iomeprol was measured by energy-dispersive X-ray¯uorescence analysis [11] . The test range was between 0.01 and 2 mg iodineuml. Plasma samples were diluted until their iodine content was in the linear part of the standard curve. Plasma concentrations of creatinine and urea were determined on a Modular 
Statistical analysis
Data are given as means"SEM. Statistical analysis was performed using multivariate analysis of variance (ANOVA) followed by Bonferroni-testing (Instat for Macintosh, Graphpad Software). Signi®cance was de®ned as P-0.05.
Results
The mean time between the administration of contrast medium and the beginning of dialysis was 1.2"0.6 h. Characteristics of patients are given in Table 1 . The distribution of patients in the groups were not different regarding weight, dose of contrast medium administered and number of patients not yet on dialysis (Table 1 ). Serum creatinine for the patients not yet on chronic dialysis were not signi®cantly different between groups (Table 1) .
Data for contrast medium clearance and extraction ratio, elimination t 1u2 of contrast medium, creatinineand urea clearance and net ultra®ltration rate are given in Table 2 . The highest contrast medium-clearance was observed for HDF, followed by High-HD, Low-HD and HF ( Table 2 ). The same was true for contrastmedium extraction ratios. The values for clearance and extraction ratios were signi®cantly different between Low-HD and High-HD, between Low-HD and HDF and between HDF and HF, but not between HDF and High-HD. HDF decreased the concentration of contrast medium signi®cantly faster than HF. There were no signi®cant differences in elimination t 1u2 of contrast medium between HDF, High-HD and Low-HD. The lowest creatinine and urea clearance was observed with HF, the highest with HDF (Table 2 ). Net ultra®ltration rates were highest with Low-HD but not signi®cantly different between groups.
Discussion
This is the ®rst randomized study comparing the ability of different dialysis modalities to remove contrast media in vivo. The observation that HDF is superior to HF and Low-HD for elimination of contrast media is in accordance with in vitro studies: Gouge et al. [8] reported higher clearances for a high-¯ux dialyser compared to a low-¯ux dialyser, especially at higher ultra®ltration rates. Okahisa et al. [9] employed a bovine blood tank model and reported that HDF removes contrast media more effectively than HF. In contrast, Matzkies et al. [10] demonstrated no difference in iopromide clearance between high-¯ux and low-¯ux dialysers in vivo. The authors claimed that elimination of iopromide is not dependent on the pore size of the membrane during haemodialysis. The reason for this discrepancy is unclear. The only difference between their study and ours is the higher blood¯ow rates in the investigation by Matzkies et al. [10] (250 vs 200 mlumin). It is possible that higher net ultra®ltration rates in the low-¯ux group contributed to higher elimination rates for contrast media, but no data for net ultra®ltration rates are given in the cited study [10] .
We included both patients on chronic dialysis treatment and those with chronic renal failure not yet on renal replacement therapy. Although the number of patients with residual renal function were similar in all groups, the degree of residual renal function was different (Table 1) . Patients not on chronic dialysis in the Low-HD group had a higher serum-creatinine than in the other groups. Besides the fact that this difference was not statistically signi®cant, an unequal distribution of residual renal function between groups does not affect dialyser clearance or extraction ratio. Residual renal function may in¯uence the total elimination of contrast media and therefore the elimination t 1u2 , but not the extracorporeal clearance of contrast media calculated 1 h after start of treatment from pre-and post-dialyser contrast-medium concentrations, blood ow, and haematocrit. Prophylactic haemodialysis' has been proposed to prevent RCN based on observations that contrast media can be removed by haemodialysis. Moon et al. [12] dialysed patients with chronic renal failure immediately after angiographic procedures and reported no increase in serum creatinine in these patients. The authors claimed that haemodialysis prevented RCN but this study did not provide an undialysed control group. Lehnert et al. [7] randomized patients to haemodialysis or conservative treatment after administration of contrast medium and failed to demonstrate a bene®cial effect of haemodialysis on RCN. However, in order to have a clinical impact on RCN, the employed treatment must remove contrast medium rapidly and ef®ciently. Our data suggest that HDF or High-HD with high blood¯ow rates should be used in future studies investigating the usefulness of extracorporeal treatments to prevent RCN.
From the present data, we cannot recommend or reject the usefulness of`prophylactic haemodialysis' to prevent RCN. Even the most effective method to remove RCN may have no bene®cial effect on RCN when employed too late. In our study, the mean interval between administration of contrast media and extracorporeal treatment was 1.2"0.6 h. A shorter interval is clinically not feasible unless haemodialysis is performed during the radiological procedure. Contrast media cause a rapid increase followed by a sustained decrease in renal blood¯ow [13, 14] . The ischaemia caused by renal vasoconstriction is one of the pathophysiological mechanisms leading to RCN. On the other hand, direct cellular toxicity may be another factor, and if toxicity on tubular cells occurs after ®ltration of contrast media, there might be a substantial delay between administration of contrast media and onset of RCN. To date it is dif®cult to determine which factor is the more important for causing RCN [2] . If toxicity on tubular cells after glomerular ®ltration of contrast media is the major pathogenetic mechanism for RCN, even a delayed removal of contrast media may be clinically bene®cial. It must be noted that even with the most ef®cient method employed (HDF), the elimination t 1u2 for contrast media was still 95"25 min. Since we did not assess possible redistribution of contrast media after treatment, it remains uncertain whether HDF is able to contribute signi®cantly to total body clearance in addition to endogenous clearance. Randomized studies employing effective methods to remove contrast media have to be performed to clarify the clinical impact of`prophylactic haemodialysis' to prevent RCN.
